| Bioactivity | Cilastatin-15N,d3 is a 15N-labeled and deuterium labeled Cilastatin. Cilastatin (MK0791) is a reversible, competitive renal dehydropeptidase I inhibitor with an IC50 of 0.1 μM. Cilastatin inhibits the bacterial metallob-lactamase enzyme CphA with an IC50 of 178 μM. Cilastatin is an antibacterial adjunct[1][2][3]. | ||||||||||||
| Invitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[5]. | ||||||||||||
| Name | Cilastatin-15N,d3 | ||||||||||||
| CAS | 2738376-83-3 | ||||||||||||
| Formula | C16H23D3N15NO5S | ||||||||||||
| Molar Mass | 362.46 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Cilastatin-15N,d3
CAS: 2738376-83-3 F: C16H23D3N15NO5S W: 362.46
Cilastatin-15N,d3 is a 15N-labeled and deuterium labeled Cilastatin. Cilastatin (MK0791) is a reversible, competitive re
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.